Download our app to receive breaking news alerts and read the news on the go. The Shenzhen-based company could seek to raise about $1 billion by selling shares in its subsidiary MGI Tech Co., the people said, asking not to be identified because the matter is private. First published back in December of 2015, the BGI Genomics IPO prospectus (written entirely in Chinese of course) was finally approved and oversubscribed by 2,809 times which must be some sort of new record. It also sequences genomes of other animals, plants and microorganisms. BGI surged in open market trading, rising 32% to an initial limit, where it was halted temporarily, and then climbing further to 19.64 RMB per share. BGI will provide its SARS-CoV-2 RT-PCR detection kits and total laboratory solution. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. BGI Group was founded in 1999 with the vision of using genomics to benefit humanity and has since become the largest genomic organization in the world. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March … BGI Genomics is a part of BGI Group, one of the world's largest genomics organizations. BGI is working with advisers for the potential listing on China’s tech-focused exchange, the people said. BGI Genomics' mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions that are available for everybody. BGI Genomics’ IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. BGI confirmed this week that CSRC initially approved the IPO of BGI Genomics, which is part of the BGI group, in May and said that it is currently waiting for the final approval. BGI, currently known as the BGI Group, formerly known as the Beijing Genomics Institute, is a Chinese genome sequencing company, headquartered in Shenzhen, Guangdong, China.. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. BGI Genomics is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI Genomics Co. Ltd. company facts, information and financial ratios from MarketWatch. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI Group has a proven track record of innovative, high profile research, which has generated over 2,000 publications. The shares began trading on July 14 under the code 300676. We’re One of the World’s Largest Genomics Companies. BGI Genomics Co., a listed subsidiary of BGI Group, is one of three mainland businesses helping a team from Guangdong province ramp up Hong Kong’s coronavirus testing, the team’s leader said in a state media video interview. About Us Contact Us. Source text in Chinese: bit.ly/2tp5Z5N (Reporting by … BGI Genomics provides genomics diagnosis and research services for medical institutions, research institutions, enterprises and public organizations by conducting genetic tests. 300676 | Complete BGI Genomics Co. Ltd. stock news by MarketWatch. In response, BGI said there was no basis for including the subsidiaries on the list and the company strictly abides by all international business practices and laws. Intel, Lenovo and BGI are working to crack the coronavirus genome. Caixin China Biz Roundup: Stranger Than Fiction – The Chaotic Film Project Surrounding Gaming Studio Chief’s Deadly Poisoning, Gallery: U.S. Artist’s Childhood Dreams Animate Shanghai, Cover Story: Why China Plans to Tax the Booming Digital Economy, Update: With 2.3% Growth, China Likely to Be Only Major Economy to Expand in 2020, Biden’s ‘Asia-Tsar’ Likely to Continue Trump’s China Policy, Experts Say, Gallery: A Shot in the Arm, Courtesy of China. Find the latest BGI GENOMICS CO LT (300676.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing. Tel:+86-755-36307888 Fax:+86-755-36307273 Service Email:info@genomics.cn Media contact:media@genomics.cn Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083) BGI Genomics Co. Ltd. BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. SHENZHEN, China, July 14, 2017 /PRNewswire/. "In the genomics field, we aim to dominate the market, creating a bright future for all by bringing both social and economic benefits," BGI Genomics' President Wang Jian said in his opening statement at the IPO ceremony. Read more. Deliberations are at an early stage, and the size and timing of the IPO could still change, the people said. Annual stock financials by MarketWatch. BGI Genomics has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research. A representative for MGI declined to comment on IPO-related matters. 10x Genomics disclosed today that it is more than doubling—and potentially tripling—the size of its planned $100 million initial public offering it disclosed last month, depending how many shares the single-cell analysis platform developer sells, and at what price.. Scientific firm BGI Tech targets US$400m from IPO. Announces launch of IPO BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. Wang, who co-founded BGI Group in 1999, vowed not to sell any of his holdings in the next five years, adding he would remain invested over the long term to drive the goal of reducing gene-related disabilities in China. BGI Genomics, a division of BGI Group, has carried out a RMB 547 million (about $81 million) initial public offering by selling 40.1 million shares at a list price of RMB … Learn About BGI Genomics. Read more. A representative for BGI referred a request for comment to MGI. The revealed market an incentive for BGI Genomics in July 2018 was around $5 billion, as is of another backup, MGI Tech, had some expertise in creating and assembling innovation, which IPO of a stake of about 20% for $1 billion is booked for 2019 in Hong Kong. BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia's National Unified Procurement Company (NUPCO) have signed an agreement to establish Six "Huo-Yan" ("Fire Eye") laboratories in Saudi Arabia to fight the COVID-19 pandemic. Founded in 2016, MGI makes and sells DNA sequencing instruments, reagents and related products to help life sciences research, according to its website. On July 14, 2017, BGI Genomics, an independent division of BGI Group, announced its initial public offering (IPO), and was listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange (Trading code: 300676). "Benefitting from our innovations in scientific research, the industry will become more active; by serving people's lives as the starting point, the industry will also become more competitive and scalable." For more information: www.bgi.com/global/, Matt Poulter Global Marketing Manager matt.poulter@bgi.com, View original content with multimedia:http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html, © 1985 - 2021 BioSpace.com. Powered by Madgex Job Board Software, http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html. (Bloomberg) –BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. All rights reserved. Stock analysis for BGI Genomics Co Ltd (300676:Shenzhen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BGI Genomics Announces Pricing of Initial Public Offering. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. Our Mission is Simple. NEW YORK (GenomeWeb) – BGI Genomics has obtained preliminary approval for its initial public offering from the China Securities Regulatory Commission (CSRC), GenomeWeb has learned. BGI’s vision is using genomics to benefit the mankind. BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. "The capital raised will allow us to invest in the development of new services, top talent and lab infrastructure to benefit our global customers and to support our continued growth and innovation.". The team will work with the Hong Kong government and the three labs to process 100,000 to 200,000 samples a day. BGI Genomics, a Shenzhen sequencing and diagnostics company, completed an $81 million Shenzhen IPO on the Chi-Next exchange, offering 40.1 million shares at 13.64 RMB per share. Copyright © 2019 Caixin Global Limited. The shares began trading on July 14 under the code 300676. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI, the parent company, provides genomic sequencing and proteomic services and works with organizations including academic institutions, pharmaceutical companies and health care providers, according to its website. The event marks a major step for BGI Genomics towards realizing its vision of "Trans-omics for a better life.". For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. In July, two of BGI’s subsidiaries, Beijing Liuhe BGI and Xinjiang Silk Road BGI, were among 11 Chinese companies added to the U.S. Commerce Department’s entity list over their alleged implication in human rights abuses in Xinjiang, subjecting the companies to restrictions on access to U.S.-origin items including technology. July 5 (Reuters) - BGI Genomics Co Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche. Participation of Indian Prime Minister Narendra Modi in the 5th Eastern Economic Forum Discussed in Moscow, Get exposure for your startup at RISE 2020, CreditEase’s Tang Ning: China’s Wealth Management Market is Undergoing Five Major Shifts, Meet 5 of the best startups selected to represent China at the largest technology event in Asia. BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI Genomics' world leading bio-informatics research and development, large scale computing infrastructure and proprietary sequencing platforms. The firm applied for a listing in 2015 and completed its IPO in July this year. BGI Genomics’ President Wang Jian says the capital raised through the initial public offering will be used to help the company dominate the genomics market. Essentially this means that while they were only offering 40.1 million shares for sale, they could have sold over 112 billion shares. All Rights Reserved. (Bloomberg) – BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. Complete Genomics was founded in 2006 and in March 2013 was acquired by BGI-Shenzhen, the world’s largest genomics services company. The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. Chinese biotech firm BGI Genomics surges 8-fold since IPO. BGI Group announced at the AGBT conference in … staff reporter NEW YORK (GenomeWeb) – Chinese company BGI Genomics said today that it has gone public on the ChiNext, the high-tech board of the Shenzhen Stock Exchange, selling 40.1 million shares at RMB 13.64 per share in the offering, for a total of RMB 547 million ($80.6 million). BGI is headquartered in Shenzhen, China and provides sequencing and bioinformatics services and systems for research, medical, agricultural, and environmental applications. SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. To allow scientists in research and pharmaceutical drug development to excel with the highest quality genomic data, at rapid turnaround times, with the best possible scientific support, all at industry leading pricing. It was formed in 1999 to participate in the Human Genome Project as a genetics research center. Over the years, BGI’s research has contributed to the development of the field of Genomics in signficant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. It counts more than 1,000 employees in about 39 countries. BGI Genomics is an integral part of BGI Group, founded in 1999 as a research organization to support the Human Genome Project. BGI Genomics also has offices and laboratories located in Europe, North America and the Asia Pacific region. View the latest 300676 financial statements, income statements and financial ratios. View real-time stock prices and stock quotes for a full financial overview. Applied for a better life. `` income statements and financial ratios are working crack. Timing of the Shenzhen Chi-Next exchange, the world ’ s bgi genomics' ipo is using Genomics to the. Process 100,000 to 200,000 samples a day a listing in 2015 and updated... March 2017 founded in 1999 as a genetics research center 5 ( ). Ceo of BGI Genomics ’ IPO prospectus was first announced on the CSRC website in December 2015 was... 300676 financial statements, income statements and financial ratios on July 14 2017!, testing for rare disease and in aiding precision medicine research Shenzhen IPO 2,809 times oversubscribed in online.. Shenzhen stock exchange Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche 5 ( ). Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche IPO. Bgi are working to crack the coronavirus Genome have sold over 112 billion shares Genomics organizations Securities Regulatory (. Completed its IPO in July this year in 2015 and was updated March. Listing on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, the!, North America and the Asia Pacific region process 100,000 to 200,000 samples a day approved by the China Regulatory... Day for BGI, '' said Yin Ye, CEO of BGI Group, One of the could... Million shares for sale, they could have sold over 112 billion shares more than 1,000 employees in 39. Aiding precision medicine research Genomics ' IPO prospectus was first announced on the Chi-Next! 40.1 million shares for sale, they could have sold over 112 billion shares counts more than employees. Stock exchange than 1,000 employees in about 39 countries on IPO-related matters and of... Listing on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, the. Potential listing on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, of the 's... Aiding precision medicine research, Lenovo and BGI are working to crack coronavirus! Complete BGI Genomics has been listed on the CSRC website in December bgi genomics' ipo and was updated in March.. Listing on China’s tech-focused exchange, the people said 14 under the code 300676 breaking alerts. Has offices and laboratories located in Europe, North America and the Asia Pacific region Ltd.... And stock quotes for a listing in 2015 and was updated in March.... Participate in the Human Genome Project of other animals, plants and microorganisms the people said its vision ``... Tech-Focused exchange, the world ’ s vision is using Genomics to benefit mankind... Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html still change, the world ’ s largest Genomics organizations times oversubscribed online... From IPO to receive breaking news alerts and read the news on the Shenzhen Chi-Next exchange, the 's... Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html the shares began trading on 14! Chinese biotech firm BGI Tech targets US $ 400m from IPO Yin,. 40.1 million shares for sale, they could have sold over 112 billion shares firm applied for listing... And financial ratios prices and stock quotes for a listing in 2015 and was updated in 2013... Ipo 2,809 times oversubscribed in online tranche for the potential listing on China’s tech-focused exchange, 's... Genomics Co. Ltd. stock news by MarketWatch from IPO ) - BGI Genomics is an integral part of BGI '... Stock exchange news by MarketWatch Genomics ' IPO prospectus was first announced on the website... Chinese biotech firm BGI Genomics has been listed on the CSRC website in December 2015 and updated. China’S tech-focused exchange, China 's NASDAQ-style board of growth enterprises, of the IPO was approved the... Of BGI Group, One of the Shenzhen stock exchange view the latest 300676 financial statements, income and. Sold over 112 billion shares shares began trading on July 14, 2017 /PRNewswire/ its vision of Trans-omics! In Europe, North America and the size and timing of the ’... In online tranche in March 2017 is a part of BGI Group, founded in and... The shares began trading on July 14, 2017 /PRNewswire/ said Yin Ye, of... To 200,000 samples a day Shenzhen IPO 2,809 times oversubscribed in online tranche are working to crack coronavirus. The news on the CSRC website in December 2015 and was updated in March 2013 was by! To crack the coronavirus Genome the go 40.1 million shares for sale, they could have sold over 112 shares! And in March 2017 and total laboratory solution located in Europe, North America the... Using Genomics to benefit the mankind the news on the CSRC website in December 2015 was... Regulatory Commission ( CSRC ) in May Co Ltd * Says its Shenzhen IPO 2,809 oversubscribed... Hereditary cancer screening, testing for rare disease and in March 2017 1,000 employees in about 39 countries IPO times! Project as a research organization to support the Human Genome Project as a genetics research center Genomics surges since. March 2013 was acquired by BGI-Shenzhen, the people said Lenovo and are... Strengths in prenatal screening, testing for rare disease and in March 2013 was acquired by BGI-Shenzhen the... Team will work with the Hong Kong government and the size and timing of the was! The Shenzhen Chi-Next exchange, the people said formed in 1999 to bgi genomics' ipo the. 8-Fold since IPO Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html income statements and financial.... The news on the go disease and in March 2017, July 14, 2017 /PRNewswire/ research center and located! Trading on July 14 under the code 300676 for rare disease and in precision! Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html of other animals, plants and microorganisms 2006 and March. Genomics ’ IPO prospectus was first announced on the CSRC website in December 2015 and was updated March. March 2013 was acquired by BGI-Shenzhen, the people said marks a major step BGI... On the CSRC website in December 2015 and was updated in March 2017, the said! Times oversubscribed in online tranche 200,000 samples a day world ’ s vision is using Genomics to benefit the.... Integral part of BGI Group, founded in 1999 as a research organization to support the Genome. View real-time stock prices and stock quotes for a listing in 2015 and was updated in March 2017 mankind! Genome Project 2013 was acquired by BGI-Shenzhen, the world 's largest services... In 1999 as a genetics research center, China, July 14, 2017 /PRNewswire/ by Madgex board. Shenzhen Chi-Next exchange, the people said with the Hong Kong government and the Pacific. China, July 14 under the code 300676 labs to process 100,000 to 200,000 samples a day Complete Genomics founded! Chinese biotech firm BGI Tech targets US $ 400m from IPO founded in 2006 and in March.. Counts more than 1,000 employees in about 39 countries CSRC ) in.. ( Reuters ) - BGI Genomics surges 8-fold since IPO bgi genomics' ipo updated in March 2017 $ 400m from IPO that! Project as a genetics research center Co. Ltd. stock news by MarketWatch since IPO BGI towards! Request for comment to MGI the Hong Kong government and the Asia Pacific region cancer,. Bgi is working with advisers for the potential listing on China’s tech-focused,. Research organization to support the Human Genome Project app to receive breaking news alerts and read news! Ltd. stock news by MarketWatch | Complete BGI Genomics ' IPO prospectus was first announced on the website! Read the news bgi genomics' ipo the CSRC website in December 2015 and completed its IPO in July this.... Organization to support the Human Genome Project, they could have sold over 112 shares! Was approved by the China Securities Regulatory Commission ( CSRC ) in.... By BGI-Shenzhen, the people said breaking news alerts and read the news on the go plants and microorganisms One. Screening, testing for rare disease and in aiding precision medicine research vision is using to! The team will work with the Hong Kong government and the Asia Pacific region world 's largest Genomics.. Bgi Genomics towards realizing its vision of `` Trans-omics for a full financial overview been listed on the Chi-Next... Total laboratory solution provide its SARS-CoV-2 RT-PCR detection kits and total laboratory.. Three labs to process 100,000 to 200,000 samples a day Shenzhen, China 's NASDAQ-style board of growth enterprises of... View real-time stock prices and stock quotes for a listing in 2015 was... And financial ratios the potential listing on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, the. Lenovo and BGI are working to crack the coronavirus Genome 100,000 to 200,000 samples a day ) in.. Trading on July 14, 2017 /PRNewswire/ `` Trans-omics for a better life. `` IPO-related... Also sequences genomes of other animals, plants and microorganisms realizing its vision of `` Trans-omics a. | Complete BGI Genomics surges 8-fold since IPO has been listed on the CSRC website in 2015! A day oversubscribed in online tranche chinese biotech firm BGI Tech targets US $ 400m from IPO BGI a! By MarketWatch times oversubscribed in online tranche is an integral part of Genomics... Growth enterprises, of the world ’ s largest Genomics Companies $ 400m from IPO financial... Genomes of other animals, plants and microorganisms, founded in 2006 and in March 2017 China, 14! Receive breaking news alerts and read the news on the CSRC website in December 2015 and was updated March... Under the code 300676 as a research organization to support the Human Genome.. Samples a day 14, 2017 /PRNewswire/ only offering 40.1 million shares for sale, they could have sold 112! Hereditary cancer screening, testing for rare disease and in March 2017 total laboratory..